The role of the growth hormone/insulin-like growth factor system in visceral adiposity

Research output: Contribution to journalReview articlepeer-review

Abstract

There is substantial evidence that the growth hormone (GH)/insulin-like growth factor (IGF) system is involved in the pathophysiology of obesity. Both GH and IGF-I have direct effects on adipocyte proliferation and differentiation, and this system is involved in the cross-talk between adipose tissue, liver, and pituitary. Transgenic animal models have been of importance in identifying mechanisms underlying these interactions. It emerges that this system has key roles in visceral adiposity, and there is a rationale for targeting this system in the treatment of visceral obesity associated with GH deficiency, metabolic syndrome, and lipodystrophies. This evidence is reviewed, gaps in knowledge are highlighted, and recommendations are made for future research.
Original languageEnglish
Pages (from-to)1-10
JournalBiochemistry Insights
Volume10
DOIs
Publication statusPublished - 20 Apr 2017

Fingerprint

Dive into the research topics of 'The role of the growth hormone/insulin-like growth factor system in visceral adiposity'. Together they form a unique fingerprint.

Cite this